Progenics Pharmaceuticals Inc. (PGNX) Given New $11.00 Price Target at BTIG Research

Progenics Pharmaceuticals Inc. (PGNX) Given New $11.00 Price Target at BTIG Research


BTIG Research's target price would suggest a potential upside of 22.91% from the stock's previous close. PGNX has been the subject of a number of other research reports.



from Biotech News